Anesthetic Management of a Patient with Brugada Syndrome- the Use of Sugammadex in Major Abdominal Surgery LETTER TO THE EDITOR

Brugada Syndrome (BS) is a rare genetic condition affecting ionic channels of the heart, predisposing patients to poten-tially fatal ventricular arrhythmias. It generally manifests during young adulthood, more frequently in males. Typical ECG pattern shows ST-segment elevation followed by a negative T wave in right pre-cordial leads, in the absence of structural heart disease. Three patterns can be recognized: 1) coved; 2) saddleback and 3) coved or saddleback with ST < 1 mm. These can co-exist and ECG may be temporarily normal. Diagnosis is made in the presence of ECG pattern type 1 and reinforced by clinical criteria like syncope, nocturnal agonal respiration, palpitations or dizziness, documented ventricular fi brillation/tachycardia and family history of BS or sudden cardiac death (SCD). Provocative tests can be made with sodium channel blockers. Cardiac defi brillator (ICD